药物联合亲情干预治疗多动症合并品行障碍对照研究  

A control study of drug combined with familial affection intervention in the treatment of hyperkinetic conduct disorder

作　　者：朱颖[1] 王莹[2] 

机构地区：[1]天津市安宁医院,中国·天津300300 [2]天津市安定医院

出　　处：《临床心身疾病杂志》2010年第5期442-443,共2页Journal of Clinical Psychosomatic Diseases

摘　　要：目的 探讨药物联合亲情干预治疗多动症合并品行障碍患儿的临床疗效. 方法 将30例家属同意进行药物治疗的多动症合并品行障碍患儿设为研究组,30例家属不同意进行药物治疗的患儿设为对照组,研究组患儿予以药物联合亲情治疗,对照组未实施任何治疗措施.观察12周.于治疗前及治疗12周末,采用Conners父母症状问卷评定临床疗效. 结果 研究组治疗后Conners父母症状问卷品行问题、学习问题、冲动多动、多动指数因子分均较治疗前有显著下降（P＜0.05或0.01）,并显著低于对照组（P＜0.05或0.01）,而对照组治疗前后均无显著变化（P均＞0.05）. 结论 药物联合亲情干预治疗多动症合并品行障碍儿童疗效显著.Objective To explore the clinical efficacy of drug combined with familial affection intervention （FAI） in the treatment of hyperkinetic conduct disorder （HCD）. Methods Thirty HCD children whose parents agreed with medication were assigned to research group treated with medication plus FAI for 12 weeks and 30 ones whose parents didn＇t agree to control group didn＇t treat. Clinical efficacies were assessed with the Conners Parent Symptom Questionnaire （PSQ） before treatment and at the end of the 12th week. Results After treatment, the scores of conduct problem, learning problem,impulsivity-hyperactivity and hyperactivity index lowered more significantly compared with pretreatment in the research group （P〈0.05 or 0.01） and were significantly lower than in the control group （P〈0.05 or 0.01） ; there were no significant changes between pre-treatment and post-treatment （all P〉0.05）. Condusion Medication plus FAI has a significant curative effect in HCD children.

关 键 词：多动症合并品行障碍 药物治疗 亲情干预 Conners父母症状问卷 儿童 

分 类 号：R749.94[医药卫生—神经病学与精神病学]